Lamivudine for treatment of spontaneous exacerbation and reactivation after immunosuppressive therapy in patients with hepatitis B virus infection. (Q45402594)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Lamivudine for treatment of spontaneous exacerbation and reactivation after immunosuppressive therapy in patients with hepatitis B virus infection. |
scientific article |
Statements
Lamivudine for treatment of spontaneous exacerbation and reactivation after immunosuppressive therapy in patients with hepatitis B virus infection (English)
Tomoko Inoue
Hiroyuki Fuke
Norihiko Yamamoto
Keiichi Ito
Kentaro Yoneda Yutaka
Yamanaka